Block & Leviton is investigating CVRx, Inc. for potential securities law violations related to the company's delayed disclosure of issues affecting sales, growth, and revenue outlook. CVRx recently lowered its full-year revenue guidance due to challenges in sales-force hiring, high turnover, and reimbursement problems with a major Medicare Advantage payer. The company also revealed a Department of Justice civil investigative demand regarding its sales and marketing practices. The investigation aims to determine if investors were fully informed about these problems earlier. Investors who lost money in CVRx shares may be eligible to recover losses through legal action initiated by Block & Leviton.
BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...
Raymond James increased its price target for SBA Communications to $271 from $264, signaling a 68.6% upside from the current share price of $160.74. The growth is driven by rising mobile data demand, network expansions by wireless carriers, and stead...
SPX Technologies (NYSE: SPXC) recently traded near its 52-week low around $170, down about 1.6% from the previous close. Despite this, several analysts maintain positive outlooks with price targets ranging from $250 to $301, indicating potential upsi...
PBF Energy's shares have surged 173% over the past year, nearing record highs due to stronger refining margins and improved quarterly results. The company reduced its net term debt by over $1.4 billion in Q2 2026, refinanced notes, and maintained nea...
J D Wetherspoon reported an 8.6% increase in like-for-like sales in the first nine weeks of its new financial year, helped by favorable weather. However, profit before tax fell 28% to £58.60 million despite a 5.2% revenue rise to £2.24 billion, mainl...
